In a criminal information filed today in the Northern District of New York, the government charged that, between 20, Endo Pharmaceuticals Inc. “We will hold accountable those who circumvent that process in pursuit of financial gain.” “FDA’s drug approval process is designed to ensure that companies market their products for uses that are proven to be safe and effective,” said Assistant Attorney General for the Justice Department’s Civil Division Stuart F.
is a Delaware corporation headquartered in Malvern, Pa. The resolution includes a deferred prosecution agreement and forfeiture totaling $20.8 million and civil false claims settlements with the federal government and the states and the District of Columbia totaling $171.9 million. (Endo) have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today. and its subsidiary Endo Pharmaceuticals Inc. Pharmaceutical company Endo Health Solutions Inc.
